Study on effects of cytokine targeted therapy on periodontal condition in patients with rheumatoid arthritis

Trial Profile

Study on effects of cytokine targeted therapy on periodontal condition in patients with rheumatoid arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Tocilizumab (Primary) ; Adalimumab; Etanercept; Infliximab
  • Indications Periodontitis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Apr 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan.
    • 19 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top